David Yin

David Yin practices at Texas Oncology PA in Mesquite, Texas.

David Yin's NPI, 1992151153, was assigned on May 6, 2016. David Yin graduated from Albert Einstein College of Medicine in 2016. David Yin holds Texas license T5242.

David Yin's primary practice is Texas Oncology PA, at 4700 N Galloway Ave, Mesquite, TX 75150 in Dallas County. The practice phone is (972) 997-8000.

David Yin's primary practice is Texas Oncology PA in Mesquite, Texas. David Yin is also affiliated with Baylor Scott & White Medical Center - Lake Pointe. The medical group on file is Texas Oncology. Dmand AI also links David Yin to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where David Yin practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is David Yin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. David Yin is board certified in hematology by the American Board of Internal Medicine. Dmand AI has David Yin's licenses on file in 6 states: Texas, Massachusetts, Florida, Maryland, Ohio and Virginia.

Dmand AI lists chronic anemia, deep vein thrombosis (DVT), purpura and thrombocytopenia and varicose veins among the conditions David Yin treats.

CMS data shows 9,601 Medicare services from David Yin across 30 procedure codes in 2024, for 228 Medicare patients. Medicare paid $74,856 for them. Every service was in an office.

CMS counts 228 Medicare patients who saw David Yin in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts David Yin's median patient age at 68, with 59% women.

In 2024, David Yin wrote 397 Medicare Part D claims for 101 patients. 68% of them were for generic drugs. CMS names the drug for 184 of them, across 9 drugs with 11 or more claims each, at $191,762 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for David Yin for performance year 2024, reported through an alternative payment model (APM). David Yin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to David Yin, published from 2017 to 2023. David Yin's most frequent co-authors are Mohammad Ibrahim Barouqa, MD, Henny H. Billett, MD and Kateryna Fedorov.

CMS Open Payments shows 127 general payments to David Yin from 30 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 96% of the total. Novartis Pharmaceuticals Corporation paid the most, $362.

David Yin graduated from Albert Einstein College of Medicine in 2016.

David Yin is in network with 22 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.